Combined use of electroconvulsive therapy and amantadine in adolescent catatonia precipitated by cyber-bullying

Journal of Child and Adolescent Psychopharmacology

Volumn 23, Issue 3, 2013, Pages 228-231

  Goetz, Michal ^a   Kitzlerova, Eva ^b   Hrdlicka, Michal ^a   Dhossche, Dirk ^c  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ARIPIPRAZOLE; CLONAZEPAM; OLANZAPINE; RISPERIDONE;

ADJUVANT THERAPY; ADOLESCENT; AGGRESSION; AUDITORY HALLUCINATION; BRIEF PSYCHOTIC DISORDER; BULLYING; CASE REPORT; CATATONIA; CONFUSION; DELUSION; DISTRACTIBILITY; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOLALIA; ELECTROCONVULSIVE THERAPY; EVENING DOSAGE; FEMALE; FOLLOW UP; GESTURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; IMMOBILIZATION; INCONTINENCE; INTERNET; LETTER; MONOTHERAPY; MORNING DOSAGE; MUTISM; PEDIATRIC PHYSIOTHERAPY; PSYCHOSIS; RESTLESSNESS; SEMI STRUCTURED INTERVIEW; SEPARATION ANXIETY; SIDE EFFECT; STRESS; WEIGHT GAIN;

ADOLESCENT; AMANTADINE; BULLYING; CATATONIA; COMBINED MODALITY THERAPY; DOPAMINE AGENTS; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; INTERNET; N-METHYLASPARTATE;

EID: 84876732603     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2012.0045     Document Type: Letter

References (30)

1. Arseneault L, Cannon M, Fisher HL, Polanczyk G, Moffitt TE, Caspi A: Childhood trauma and children's emerging psychotic symptoms: A genetically sensitive longitudinal cohort study. Am J Psychiatry 168: 65-72, 2011.
2. Askenazy F, Dor E, Benoit M, Dupuis G, Serret S, Myquel M, Seddiki Y: Catatonia in a 14 year-old girl: Treatment with clonazepam and carbamazepine, a 10-year follow-up [in French]. Encephale 36: 46-53, 2010.
3. Bauer J, Pedersen MO, Jorgensen MB. Should the term catatonia be explicitly included in the ICD-10 description of acute transient psychotic disorder F23. 0? Nord J Psychiatry 66: 68-69, 2012
4. Bonner CA, Kent GH: Overlapping symptoms in catatonic excitement and manic excitement. Am J Psychiatry 92: 1311-1322, 1936.
5. Carroll BT, Goforth HW, Thomas C, Ahuja N, McDaniel WW, Kraus MF, Spiegel DR, Franco KN, Pozuelo L, Muñoz C: Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. J Neuropsychiatry Clin Neurosci 19: 406-412, 2007.
6. Carroll BT, Lee JW, Appiani F, Thomas C: Pharmacotherapy of catatonia. Prim Psychiatry 17: 41-47, 2010.
7. Ceylan MF, Kul M, Kultur SE, Kilincaslan A: Major depression with catatonic features in a child remitted with olanzapine. J Child Adolesc Psychopharmacol. 20: 225-227, 2010.
8. Cohen D, Flament M, Dubos P-F, Basquin M: Catatonic syndrome in young people. J Am Acad Child Adolesc Psychiatry 38: 1040-1046, 1999.
9. Consoli A, Benmiloud M, Wachtel L, Dhossche D, Cohen D, Bonnot O: Electroconvulsive therapy in adolescents with the catatonia syndrome: efficacy and ethics. J ECT 26: 259-265, 2010.
10. DelBello MP, Foster KD, Strakowski SM: Case report: Treatment of catatonia in an adolescent male. J Adolesc Health 27: 69-71, 2000.
11. Dhossche DM, Ross CA, Stoppelbein L: The role of deprivation, abuse, and trauma in pediatric catatonia without a clear medical cause. Acta Psychiatr Scand 125: 25-32, 2012.
12. Dhossche DM, Wachtel LE: Catatonia is hidden in plain sight among different pediatric disorders: a review article. Pediatr Neurol 43: 307-315, 2010.
13. Dudova I, Hrdlicka M: Successful use of olanzapine in adolescent monozygotic twins with catatonic schizophrenia resistant to electroconvulsive therapy: Case report. Neuro Endocrinol Lett 29: 47-50, 2008.
14. Esmaili T, Malek A: Electroconvulsive therapy (ECT) in a six-yearold girl suffering from major depressive disorder with catatonic features. Eur Child Adolesc Psychiatry 16: 58-60, 2007.
15. Fink M, Taylor MA. Catatonia: A Clinician's Guide to Diagnosis and Treatment. Cambridge: Cambridge University Press; 2003.
16. Fink M, Taylor MA: The catatonia syndrome: Forgotten but not gone. Arch Gen Psychiatry 66: 1173-1177, 2009.
17. Fink M, Taylor MA: Neuroleptic malignant syndrome is malignant catatonia, warranting treatments efficacious for catatonia. Prog Neuropsychopharmacol Biol Psychiatry. 30: 1182-1183, 2006.
18. Ghaziuddin N, Dhossche D, Marcotte K: Retrospective chart review of catatonia in child and adolescent psychiatric patients. Acta Psychiatr Scand 125: 33-38, 2012.
19. Kelleher I, Harley M, Lynch F, Arseneault L, Fitzpatrick C, Cannon M: Associations between childhood trauma, bullying and psychotic symptoms among a school-based adolescent sample. Br J Psychiatry 193: 378-382, 2008.
20. Kranaster L, Hoyer C, Janke C, Sartorius A: Preliminary evaluation of clinical outcome and safety of ketamine as an anesthetic for electroconvulsive therapy in schizophrenia. World J Biol Psychiatry 2012 Mar 8. [Epub ahead of print]
21. Lewis AL, Pelic C, Kahn DA: Malignant catatonia in a patient with bipolar disorder, B12 deficiency, and neuroleptic malignant syndrome: one cause or three? J Psychiatr Pract 15: 415-422, 2009.
22. Lee JW: Neuroleptic-induced catatonia: Clinical presentation, response tobenzodiazepines, and relationship to neuroleptic malignant syndrome. J Clin Psychopharmacol30: 3-10, 2010
23. Mackie C, O'LearyBarrett M, AlKhudhairy N, CastellanosRyan N, Struve M, Topper L, Conrod P: Adolescent bullying, cannabis use and emerging psychotic experiences: A longitudinal general population study. 2012. Available on CJO doi: 10. 1017/ S003329171200205X
24. Moskowitz AK: "Scared stiff": Catatonia as an evolutionary-based fear response. Psychol Rev 111: 984-1002, 2004
25. Northoff G, Eckert J, Fritze J: Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry 62: 404-406, 1997.
26. Sourander A, Brunstein Klomek A, Ikonen M, Lindroos J, Luntamo T, Koskelainen M, Ristkari T, Helenius H: Psychosocial risk factors associated with cyberbullying among adolescents: a populationbased study. Arch Gen Psychiatry 67: 720-728, 2010.
27. Strawn JR, Delgado SV: Successful treatment of catatonia with aripiprazole in an adolescent with psychosis. J Child Adolesc Psychopharmacol 17: 733-735, 2007.
28. Trollor JN, Chen X, Sachdev PS: Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs 23: 477-492, 2009.
29. Wachtel LE, Crawford TO, Dhossche DM, Reti IM: Electroconvulsive therapy for pediatric malignant catatonia with cerebellar dysgenesis. Pediatr Neurol 43: 427-430, 2010.
30. Weiss M, Allan B, Greenaway M: Treatment of catatonia with electroconvulsive therapy in adolescents. J Child Adolesc Psychopharmacol 22: 96-100, 2012.